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The skull base is a complex anatomical region that harbors many important neurovascular
structures in a relatively confined space. The pathology that can develop at this site is
varied, and many disease processes may present with similar clinical and neuroimaging
findings. While computed tomography maintains a role in the evaluation of many entities
and can, for instance, delineate osseous erosionwith great detail and characterize calcified
tumor matrices, magnetic resonance imaging (MRI) is the mainstay in the neuroimaging
assessment of most pathology occurring at the skull base. Various MRI sequences have
proven to be robust tools for tissue characterization and can provide information on
the presence of lipids, paramagnetic and diamagnetic elements, and tumor cellularity,
among others. In addition, currently available MRI techniques are able to generate high
spatial resolution images that allow visualization of cranial nerves and their involvement
by adjacent pathology. The information obtained from such examinations may aid in the
distinction of these disease processes and in the accurate delineation of their extent prior
to biopsy or treatment planning.
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C haracterization of sellar and parasellarlesions is challenging due to theanatomical complexity of the skull base,
the extensive breadth of pathology that one may
encounter, and the similar imaging appearance
and clinical presentations of some entities. The
presence of various critical neurovascular struc-
tures in a confined space complicates surgical
access for tissue diagnosis or resection and under-
scores the importance of appropriate imaging.
We review relevant neuroimaging aspects of
sellar and parasellar lesions with particular
attention to the anterior skull base.
RELEVANT ANATOMY
AND EMBRYOLOGY
Pituitary Embryology
The adenohypophysis derives from a diver-
ticulum that arises from the primitive oral
cavity (Rathke’s pouch) and projects toward
the central skull base at around weeks 4 and
5.1,2 A diencephalic infundibulum then projects
inferiorly and contacts the diverticulum, which
loses its connection to the oral cavity.2 The
anterior wall of the pouch fills with cells and
forms the pars distalis, leaving a small cleft
between it and the posterior wall, which becomes
the pars intermedia.3 A small infundibular
process grows superiorly and becomes the pars
tuberalis.2 The posterior diencephalic tissue
evolves into the neurohypophysis.4
Anatomy of the Sphenoid Bone
The sphenoid bone is the largest component
of the anterior skull base. Understanding its
complex anatomy is key in evaluating sellar
and parasellar pathology due to the popularity
of endoscopic approaches to access many of
these lesions.5 The sphenoid bone holds the
pituitary gland within the sella and adjacent
structures, including cavernous sinuses and
traversing cranial nerves. It features numerous
foramina and fissures through which neurovas-
cular structures pass. The sphenoid body is
situated in the midline and has a cuboidal
shape. Anterolaterally and superiorly, it extends
as the greater wings forming the anteromedial
aspects of the middle cranial fossae. The carotid
sulci are located above their attachment to
the sphenoid body lodging the internal carotid
arteries and lateral cavernous sinuses. The
lesser wings project posterolaterally, forming the
superior orbital fissures between themselves and
the greater wings. The flat surface connecting
the lesser wings is the planum sphenoidale.
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TABLE. Pituitary MRI Protocol at Our Institution
Sequence Slice thickness (mm)
Precontrast
Sagittal T1 3
Axial T2 3
Coronal T1 3
Coronal T2 3
Postcontrast
Coronal T1a 3
Coronal T1 3
Sagittal T1 3
Axial T1-MPRAGE 1
aDynamic scan with 5 slices per acquisition every 30 s for 3 min.
The sella is a saddle-shaped concavity in the sphenoid body that
is devoid of a bony covering laterally and superiorly. The pituitary
gland is lodged in the sella and bounded laterally by cavernous
sinuses, which are large venous plexuses between inner and outer
layers of dura mater. The cavernous sinuses are interconnected
via channels crossing the midline along the anterior, inferior, and
posterior pituitary surfaces. A reflection of the inner dural layer
above the pituitary gland forms the diaphragma sellae, which has
a variable-sized opening for the infundibulum.
IMAGING PROTOCOLS
Magnetic resonance imaging (MRI) is a mainstay in the
evaluation of sellar and parasellar pathology, due to intrinsic
high-contrast resolution and availability of advanced sequences
FIGURE 1. Microadenoma. A, Coronal and B sagittal postcontrast T1-weighted images demonstrate a
small hypoenhancing focus in the right pituitary gland (arrow, A) abutting the right supraclinoid internal
carotid artery (arrowhead, A). Notice upward convexity of the right superior pituitary surface and slight
bulging into the suprasellar cistern without compression of the optic chiasm or nerves.
that offer high spatial resolution. Isotropic CISS (constructive
interference in steady state) or its analog FIESTA-C (fast imaging
employing steady-state acquisition cycled phases) are derived
from steady-state free precession (SSFP) sequences that are
acquired in a way that eliminates phase artifacts and generates
fluid-sensitive images with high spatial resolution in a short
period of time.6 The isovolumetric data provide excellent contrast
between fluid and surrounding tissues and can be reconstructed
in any plane.7 CISS and FIESTA-C are particularly useful for
delineating the cisternal segments of the cranial nerves due to
the bright signal from surrounding cerebrospinal fluid (CSF).
Administration of intravenous contrast material in SSFP-based
sequences allows visualization of the interdural cranial nerve
segments and may be able to depict their relationship with skull
base lesions.8,9 High-resolution cranial nerve MRI should be
performed at a minimum of 1.5 Tesla and ideally at 3.0 Tesla, as
the latter provides higher signal-to-noise ratio and increases the
conspicuity of cranial nerves.10 Isovolumetric gradient echo T1-
weighted MR sequences (volumetric interpolated brain exami-
nation, VIBE, or magnetization-prepared rapid acquisition with
gradient echo, MP-RAGE) allow for multiplanar reconstruc-
tions. However, contrast enhancement may be less conspicuous
compared to spin-echo images.11
For the pituitary gland, thinner slices are acquired with smaller
field of views centered at the sella. Dynamic contrast-enhanced
sequences are obtained in the coronal plane and acquired every
30 s for 3 min following intravenous contrast injection (Table).
These take advantage of the different contrast dynamics of
adenomas in relation to pituitary tissue and may be useful for
evaluation of small tumors.12,13 Most adenomas enhance more
slowly (peak between 60 and 200 s) than the briskly and avidly
enhancing pituitary tissue.14
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FIGURE 2. Cavernous sinus invasion and hemorrhage in a macroadenoma. A, Sagittal noncontrast T1-
weighted image shows a sellar/suprasellar mass with a hyperintense upper component due to hemorrhage. B,
Postcontrast T1-weighted image shows enhancement of the lesion except for the hemorrhagic component. C,
Axial T2-weighted image shows a blood level within the mass (arrow).D, Coronal postcontrast T1-weighted
image demonstrates definite left cavernous sinus invasion with complete encasement of the internal carotid
artery (arrowhead).
NEOPLASTIC
Pituitary Adenoma
Adenomas account for 10% to 15% of intracranial tumors.15
They have a prevalence of 17% based on a meta-analysis of
autopsy and imaging data.16 Adenomas have been arbitrarily
classified into microadenomas (<10 mm) and macroadenomas
(≥10mm).Microadenomasmay be difficult to detect due to their
size but nonetheless be highly symptomatic, while macroade-
nomas have the potential to exert mass effect. Adenomas can also
be classified according to their cellular origin into lactotrophs,
somatotrophs, gonadotrophs, corticotrophs, and thyrotrophs. In
an epidemiologic study, 74% of macroadenomas and 22% of
microadenomas were nonfunctioning.17 Functioning adenomas
secrete prolactin in 25% to 41% and adrenocorticotropic and
growth hormones in 5% and 2.8% of cases, respectively.16
Identification of small lesions may benefit from dynamic
contrast-enhanced MRI or, rarely, computed tomography (CT)
techniques (usually when MRI cannot be performed) based on
the differential rate of enhancement of adenomas compared to
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FIGURE 3. Giant invasive macroadenoma. A, Axial postcontrast T1-weighted image shows tumor
invading the cavernous sinuses, sinonasal cavity, right orbit, and left middle cranial fossa. B, Coronal
postcontrast T1-weighted image shows carotid encasement bilaterally and mass effect on the right prechi-
asmatic optic nerve.
FIGURE 4. Meningioma. Sagittal postcontrast T1-weighted image shows an
avidly enhancing meningioma along the planum sphenoidale, tuberculum
sellae, and sella turcica (arrow) with an associated dural tail (arrowhead) and
pneumosinus dilatans (star).
FIGURE 5. Meningioma. Axial postcontrast T1-weighted image demon-
strates a meningioma invading the left orbit (arrow) and posterior ethmoid
cells. Note hyperostosis of the greater sphenoid wing (white arrowhead) and
anterior clinoid process (black arrowhead).
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FIGURE 6. Craniopharyngioma in a child. A, Axial noncontrast CT image shows a partially calcified
suprasellar mass and obstructive hydrocephalus.B, coronal T2-weighted image shows the mass (black arrows)
to have cystic and solid components. C, sagittal postcontrast T1-weighted image demonstrates the sellar,
suprasellar, and prepontine extent of the tumor and areas of enhancement. D, Axial susceptibility-weighted
imaging minimum intensity projection demonstrates blooming artifact within the mass (white arrow) related
to calcification.
pituitary tissue. Normal pituitary parenchyma shows homoge-
neous enhancement at 60 to 80 s following administration of
contrast material.18 Maximum image contrast between adenomas
and pituitary tissue occurs at about 1 min and gradually decreases
thereafter (Figure 1).19 However, an adenoma may enhance
earlier than pituitary tissue due to direct arterial supply.18 While
signal intensity on T2-weighted sequences is variable (particu-
larly in large tumors) due to hemorrhage, cysts, or necrosis,20 T2
hypointensity has been commonly reported in growth-hormone-
producing adenomas.21,22
Large adenomas usually infiltrate the gland; therefore, a
displaced but otherwise normal-appearing pituitary gland may be
helpful in ruling out an adenoma. Up to 10% of adenomas invade
the cavernous sinuses (more frequently larger lesions) and tend to
be biologically aggressive, with increased surgical morbidity and
mortality.22-24 Imaging features that may be indicative or highly
suggestive of cavernous sinus invasion (or absence of such) are
usually assessed on coronal pre- and postcontrast T1-weighted
sequences.24,25 In one study, greater than 67% encasement of
the internal carotid artery by tumor (about 241◦) yielded a
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FIGURE 7. Chordoma discovered in a 10-year-old girl who presented for suspected adenoid enlargement. A, Sagittal noncon-
trast T1-weighted image shows a large mass (m) centered at the lower clivus and projecting into the pharynx and posterior
fossa with compression of the brain stem. B, Sagittal postcontrast T1-weighted image shows avid enhancement of the lesion.
C, Sagittal postcontrast CT shows erosive changes in the tip of the clivus. D, Axial T2-weighted image demonstrates marked
T2-hyperintensity of the mass with dark intervening septations in a honeycomb pattern. E, Postcontrast T1-weighted image
shows septal enhancement (arrowheads) and a more solid enhancing central component. F, Axial postcontrast CISS image
demonstrates dural disruption (arrow) and extrusion of tumor into the subarachnoid space of the posterior fossa.
100% positive predictive value (PPV) for invasion as confirmed
by surgery.24 Other imaging findings included obliteration of
the carotid sulcus venous compartment (95% PPV) and tumor
extension beyond the lateral intercarotid line (85% PPV).24
Features predicting absence of invasion include less than 25%
of carotid encasement, presence of pituitary tissue between the
tumor and carotid artery, and tumor not extending beyond the
medial intercarotid line (Figure 2).24
Five percent to 14% of surgically treated adenomas are
classified as “giant” (greater than 4 cm).15 Despite their benign
histology, such tumors can infiltrate the skull base and, rarely,
extend to the nasopharynx (Figure 3).26 Large adenomas undergo
spontaneous infarction at a greater rate than any other central
nervous system (CNS) tumor, probably due to outgrowth of
their blood supply, vascular compression from expansion, or other
intrinsic features.27,28 This occurs with or without hemorrhage
and may lead to pituitary apoplexy, which can rarely be compli-
cated by retroclival hematomas.27,29 Pituitary carcinomas are
exceedingly rare, and distant spread is the only imaging feature
that may distinguish them from adenomas.30
Meningioma
Meningiomas constitute the most common primary CNS
neoplasms, with an incidence of 7 in 100 000 individuals
according to one population-based study.31 They are 3 times
more common in females and are largely tumors of adulthood,
with greater than 70% occurring after age 55.31 Meningiomas
are rarely seen in children unless syndromic or associated with
radiation (less than 2% occur in patients 20 yr of age or
younger).32 With 15 subtypes in the 2007 WHO classification,
they are histologically heterogeneous, although most (90%)
are benign and classified as grade I.33 Six percent of menin-
giomas are anaplastic (grade II) and 5% frankly malignant
(grade III).33 Meningiomas arise from arachnoid cap cells
in the leptomeninges, which derive from the mesenchyme
and neural crest.34,35 They are almost always dural-based
(but may be intraventricular or very rarely extracranial) and
commonly occur along dural reflections. Approximately 40%
arise in the skull base.36 Roughly one-half of anterior skull
base meningiomas arise at the sphenoid wings and the
remainder from the tuberculum sellae, limbus sphenoidale, and
22 | VOLUME 80 | NUMBER 1 | JANUARY 2017 www.neurosurgery-online.com
D
ow
nloaded from
 https://academ
ic.oup.com
/neurosurgery/article-abstract/80/1/17/2645441 by U
niv of N
orth C
arolina at C
hapel H
ill H
ealth Sci Lib user on 15 August 2019
SELLAR AND PARASELLAR IMAGING
FIGURE8. Chordoma with dural disruption. A, Axial postcontrast CT image shows an erosive lesion (black arrows) involving
the left petroclival fissure and carotid canal. B, Axial noncontrast T1-weighted image shows the lesion to be mildly hyperintense
relative to CSF. C, Axial postcontrast T1-weighted image shows avid enhancement of the mass. D, Axial T2-weighted image
shows the mass to be well circumscribed and very bright. E, Axial postcontrast CISS shows the mass (thin arrows) in the left
petroclival region. Note the location of both cranial nerves 6 in the prepontine cistern (black arrowheads). F, Sagittal postcontrast
CISS shows dural disruption (white arrowhead) and subarachnoid extrusion of the mass with elevation of left cranial nerve 6
(white arrow).
chiasmatic and olfactory grooves (Figure 4).37 Therefore,
extension frequently occurs into the optic canals, cavernous
sinuses, or sella (Figure 5). Arterial encasement may be present,
which can lead to stenosis.38 Anterior skull base meningiomas
can result in abnormal dilatation of an adjacent paranasal sinus
(pneumosinus dilatans).39
On noncontrast CT, meningiomas tend to be iso- to hyper-
dense to cerebral cortex and are difficult to visualize unless they
are large or calcified or there is hyperostosis, which appears to be
more common in the skull base (occurring in 50% of patients)
compared to convexity meningiomas.40 On MRI they are usually
well circumscribed, iso- to hypointense on T2, and show avid
contrast enhancement, although this will vary according to the
degree of calcification or, rarely, cystic degeneration. Although
not entirely specific, identification of a dural tail may suggest a
meningioma if the original definition is applied: the tail must (a)
be thicker closer to the tumor and taper peripherally, (b) enhance
to a greater degree than the tumor, and (c) be seen in 2 consecutive
tumor sections and more than one plane.41,42 Studies on their
apparent diffusion coefficient (ADC) characteristics have yielded
variable results.43
Craniopharyngioma
Craniopharyngiomas are nonglial epithelial tumors arising
from remnants of Rathke’s pouch or rests of buccal mucosa at
any point along the trajectory of the craniopharyngeal duct.44
While their most common site of origin is the infundibulum,
where squamous epithelial rests are known to occur, they may
rarely arise primarily within the third ventricle, sphenoid bone,
or even nasopharynx.45 They are rare, with an incidence of 0.5 to
2 cases per million persons per year, up to half occurring during
childhood and adolescence.46 They constitute 4% of intracranial
neoplasms in the pediatric population and have a bimodal
distribution, with peaks at 5 to 14 and 50 to 75 yr of age.47,48
Histologically, craniopharyngiomas are almost always benign and
have a high survival rate, but they can be locally aggressive and
may be associated with significant morbidity.46 Those occurring
in childhood are more commonly of the adamantinomatous
type and present as heterogeneous cystic and solid suprasellar
masses (Figure 6). Approximately 90% of these have calcifi-
cations that can be readily identified on CT.44,46 The solid
portions show contrast enhancement, and on MRI the cystic
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FIGURE 9. Trigeminal schwannoma. Axial postcontrast T1-weighted image
shows an avidly enhancing schwannoma (arrow) involving the trigeminal
ganglion within Meckel cave and the cisternal segment of the nerve.
components may present with variable signal intensities
depending on their contents of protein, cholesterol, or hemor-
rhage.44 Tumors in adulthood are more commonly of the
papillary type and are solid, less commonly calcified, and devoid
of cysts.44,46 Due to their preferred infundibular location, age
at presentation, and solid appearance with lack of calcification
or cystic changes, papillary craniopharyngiomas may be difficult
to distinguish from germinomas. While they both usually show
strong contrast enhancement, germinomas have lower ADC
values by virtue of their higher grade histology and cellularity
compared to papillary craniopharyngiomas.49
Chordoma
Most chordomas are histologically low-grade but locally
aggressive tumors derived from embryonic remnants of the
notochord.50 Three subtypes have been recognized, with the
conventional form accounting for the majority, followed by
chondroid chordoma with cartilaginous elements and the rare
dedifferentiated chordomas, which are malignant and have the
worst prognosis.51,52 Half of all chordomas are sacrococcygeal,
one-third occur in the skull base, and a minority arise in the
spine.51 They are twice as common in males, have a peak
incidence between 50 and 60 yr of age, and are rare in children and
adolescents.52 These tumors most frequently occur midline at the
spheno-occipital synchondrosis, although the chondroid subtype
has a tendency to arise laterally at the petroclival junction.50,53
Chordomas are extradural and almost always originate in bone,
which may lead to bony sequestra (the chondroid variant may
have a true calcific matrix) that can be demonstrated on CT.53
On MRI, chordomas are well circumscribed with a pseudoen-
capsulated appearance and markedly bright on T2-weighted
sequences, probably secondary to mucin and/or necrosis.53 T2
signal in the chondroid variant may be relatively low due to
cartilaginous tissue.54 Interlobular septa are formed by epithe-
lioid cells and appear hypointense on T2 with variable degrees of
contrast enhancement (Figure 7).53 Chordomas are soft tumors
that tend to displace or encase blood vessels, but stenoses are
rare.55 Dural transgression can be present, and tumor can extend
FIGURE 10. Optic pathway glioma in a patient with neurofibromatosis type 1. A, Axial T2-weighted
image shows enlargement of the optic nerves bilaterally (arrows), worse on the left. B, Axial postcontrast
T1-weighted image shows heterogeneous enhancement on both sides, extending to the chiasm on the left.
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FIGURE 11. Sporadic optic pathway glioma. A, Axial T2 shows enlargement of the optic chiasm (black
arrow) and tracts (arrowhead) due to infiltrative tumor. B, Sagittal postcontrast T1 shows a mass involving
the chiasm, hypothalamus, and anterior third ventricle (white arrow) with a small focus of enhancement.
FIGURE 12. Cystic optic pathway glioma. Axial postcontrast T1-weighted
image shows a nonenhancing cystic mass (arrow) expanding the left optic nerve.
into the subarachnoid space, increasing the risk of CSF leaks and
infection.56 Dural disruption may be identified on T2-weighted
imaging but is best visualized on high-resolution SSFP-based
sequences, where administration of contrast may aid in delin-
eation of tumor against nonenhancing dura and depiction of its
relationship to cranial nerves (Figure 7).8
Chondrosarcoma
Chondrosarcomas are often described together with
chordomas, as they share similar imaging features, clinical
presentations, and locations. Both are rare and usually present
in adults between the fourth and fifth decades of life and
together constitute less than 1% of intracranial tumors.50,57
Chondrosarcomas represent 6% of all skull base tumors, and
only 1% of them occur at this site.58 Compared to chordomas,
conventional chondrosarcomas are relatively indolent and have
a more favorable prognosis.50 Metastases and recurrence are
rare, except for the unusual dedifferentiated subtype, which
has an aggressive course.59 While pathogenesis is uncertain,
chondrosarcomas are believed to arise from chondrocytes within
endochondral cartilage rests and are commonly located at the
petroclival (two-third of cases), spheno-occipital, and sphenopet-
rosal synchondroses, therefore more commonly off-midline
compared to chordomas.60,61 CT demonstrates osseous erosions
and destructive changes usually with a calcified chondroid matrix
that may have typical “rings and arcs” or nonspecific foci of
amorphous calcifications.62 Similarly, on MRI, chondrosarcomas
are usually well circumscribed and hyperintense on T2-weighted
sequences, with variable degrees of heterogeneous contrast
enhancement (Figure 8).50,57,61 As opposed to chordomas,
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FIGURE 13. Germinoma. A, Axial noncontrast CT image shows a hyperdense suprasellar mass (arrow).
B, Axial T2-weighted image shows the mass to be iso- to mildly hyperintense relative to cortex. C, Sagittal
postcontrast T1-weighted image shows heterogeneous enhancement of the mass. D, ADC map shows low
signal from the mass in keeping with restricted diffusion.
chondrosarcomas more often present with ophthalmoplegia,
presumably due to their preferred lateral location.61 Finally,
while some of their imaging features overlap, a recent study using
diffusion-weighted imaging suggests that chondrosarcomas have
significantly higher ADC values than chordomas.63
Schwannoma
Schwannomas are benign, slow-growing neoplasms that arise
from Schwann cells. They make up 8.5% of intracranial tumors
and are usually seen in adulthood, the overwhelming majority
originating from cranial nerve (CN) VIII (90%), followed by
CN V (1%-8%) and CN VII.64 In the parasellar region,
CN V schwannomas predominate, while CN III, IV, and
VI schwannomas are rare, except in the setting of neurofi-
bromatosis type 2.64 The most common location of CN V
schwannomas is the gasserian ganglion, but they can also affect
the cisternal or postganglionic segments, and the cavernous
sinus is often involved.65,66 Most patients present with CN V
dysfunction, although symptoms related to compression of CN
VI within Dorello’s canal may be present.65 On MRI, schwan-
nomas are iso- to hypointense on T1 and hyperintense on
T2-weighted sequences and show avid contrast enhancement
(Figure 9).65,67 Their heterogeneity varies according to the
presence of cystic changes or, rarely, hemorrhage or calcifica-
tions.65-67 Melanotic schwannomas are rare and show intrinsic
T1 hyperintensity, in which case they may be confused
with lipomas, although the latter suppress on fat-saturated
sequences.59,68,69
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FIGURE 14. Plasmacytoma. A, Axial postcontrast CT shows a large lytic skull base lesion (arrows). B, Axial
T2-weighted image shows the mass to be predominantly iso- to hypointense and to encase the carotid arteries
bilaterally. C, Sagittal noncontrast T1-weighted image shows that the mass (star) is hyperintense relative to
brain parenchyma. D, Axial postcontrast T1-weighted image shows diffuse and avid enhancement of the
mass.
Optic Pathway Glioma
These lesions represent 3% to 5% of brain tumors in children,
and the great majority are diagnosed before age 20.70 They
account for 65% of all optic nerve tumors, and roughly one-third
are associated with neurofibromatosis type 1.71 They are, in fact,
the most common CNS neoplasms in this syndrome, in which
they have been reported in 7% to 20% of children.70 Syndromic
optic nerve gliomas almost always develop before age 4 and are
low grade and generally indolent.72 While it appears that sporadic
gliomas are associated with worse outcomes, their presentation
differs from syndromic tumors in that the latter are usually
found in asymptomatic patients as part of routine screening and
their natural history has not been conclusively demonstrated.73
Syndromic status also has implications for tumor location. Optic
pathway gliomas in neurofibromatosis type 1 more frequently
involve the optic nerves, while sporadic ones favor a chias-
matic or postchiasmatic location (Figures 10 and 11).72,73 On
MRI, they infiltrate and cause enlargement of optic nerves,
chiasm, and/or optic tracts. They are iso- to hypointense on T1
and hyperintense on T2-weighted sequences and usually well
demarcated.73 Enhancement is variable and does not correlate
with tumor grade.74 Calcifications are uncommon and hemor-
rhage is exceedingly rare.70,72,75 Cysts may be present and are
more common in sporadic tumors (Figure 12).72 Increased T2
signal is generally not useful to evaluate involvement of the
optic tracts, as it may be also related to edema.72 Postcontrast
images may be helpful in this regard, since enhancement indicates
tumor.74
Germ Cell Tumor
Germinomas represent 50% to 70% of intracranial germ
cell tumors, with the rest belonging to the nongerminomatous
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FIGURE 15. Osseous metastasis in a patient with breast cancer. A, Axial T2-weighted image shows a
hypointense mass in the skull base (arrow) with partial carotid encasement and extension into the anterior
left Meckel cave (arrowhead). B, Axial postcontrast T1-weighted image shows enhancement of the tumor.
FIGURE 16. Rathke cleft cyst. Sagittal noncontrast T1-weighted image shows
a hyperintense cyst (arrow) displacing the pars distalis anteriorly. Note the
thin pars intermedia between the cyst and the bright posterior pituitary
(arrowhead).
subtype.76 Germ cell tumors are predominantly seen in children
and account for nearly 4% of pediatric intracranial tumors in
the United States, most of them diagnosed between 5 and 14
yr of age.48 Pure germinomas are usually diagnosed in patients
between 10 and 21 yr of age, while nongerminomatous tumors
are more often seen in younger children.76 The incidence of
intracranial germ cell tumors is significantly higher in Asian
countries and also in patients of Asian descent living in the United
States.77 Alfa-fetoprotein and β-human chorionic gonadotropin
are commonly found in CSF and serum and may be helpful
markers for diagnosis.76,78
Intracranial germ cell tumors favor a midline location around
the third ventricle.79 The majority of lesions arising in the pineal
region are nongerminomatous, while suprasellar ones are more
likely to be germinomas, with these 2 sites constituting the most
common locations.80 Five percent to 10% of germinomas are
ectopic and occur in basal ganglia or thalami.81 These have an
increased incidence in Asia and may be associated with ipsilateral
cerebral or brainstem atrophy.82 Rarely, germinomas may occur
within the sella turcica.30 While pineal germ cell tumors are most
common in males, suprasellar ones are slightly more frequent
in females.30,78 Pure germinomas are exquisitely radiosensitive,
with survival rates greater than 90% at 5 yr with radiotherapy
alone.76
The earliest finding of a suprasellar germinomamay be absence
of the pituitary bright spot due to disruption of the infundibulo-
neurohypophyseal system.30 Enhancement is typically avid and
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FIGURE 17. Intracystic nodule in a Rathke cleft cyst. A, Coronal T2-weighted image shows a dark intra-
cystic nodule (arrow). B, Sagittal noncontrast T1-weighted image shows the nodule to be very bright.
more homogeneous in germinomas compared to nongermi-
nomatous tumors, which are more commonly hemorrhagic.83
Germinomas are highly cellular and, as a result, show restricted
diffusion on MRI and are usually hyperdense on CT.83,84
Compared to nongerminomatous tumors, one study suggests that
germinomas may show lower ADC values on MRI (Figure 13).85
However, conventional imaging characteristics of germinomas
and nongerminomatous tumors are similar, and reliable discrimi-
nation between histologic subtypes is not possible.76 These lesions
are iso- to slightly hyperintense on T2-weighted images, and T1
signal intensity is variable.83,84 Cystic changes may be seen, and
calcifications are unusual (as opposed to pineal region tumors, in
which calcifications may “engulf ” the pineal gland).84 Germ cell
tumors have a high propensity to seed CSF, and therefore imaging
of the entire neuraxis is warranted.30
Plasmacytoma
Plasma cell neoplasms can present systemically as multiple
myeloma or as discrete masses in the form of plasmacytomas.86
Plasmacytomas are usually intramedullary and solitary but may
occasionally be multiple or extramedullary.86 By definition,
solitary plasmacytomas occur without other stigmata of multiple
myeloma, such as anemia, renal insufficiency, or scattered
skeletal lesions.87 Skull base plasmacytomas usually arise from
the nasopharynx, clivus, or petrous apex.88 The great majority
of patients with a solitary plasmacytoma will develop multiple
myeloma, although this appears to be less common with
extramedullary tumors.88,89 While the imaging appearance is
nonspecific to allow a preoperative diagnosis, one of their most
characteristic features onMRI is perhaps the intrinsic T1 hyperin-
tensity of some tumors, presumably related to densely packed cells
and a low water content (Figure 14).88 As opposed to chondrosar-
comas or chordomas, which are markedly hyperintense on T2,
plasmacytomas are relatively isointense to gray matter due to
high cellularity and lack a calcific matrix or areas of sequestered
bone.88,90 Plasmacytomas enhance avidly and homogeneously,
which are also features of lymphoma, but the latter tends to have
intermediate to low signal intensity on both T1 and T2-weighted
sequences.30
Metastases
Metastases to the skull base occur in approximately 4%
of cancer patients.91 While various tumors metastasize to this
region, in one literature review, the most common primaries in
order of frequency were prostate and breast cancer, lymphoma,
and lung cancer.92 Most skull base metastases probably spread
hematogenously, although seeding may also occur through the
valveless Batson venous plexus, which connects the pelvic and
thoracic venous systems with intracranial veins and sinuses.92,93
Additionally, the skull base can be involved by direct extension
of nasopharyngeal or sphenoid tumors or via perineural spread,
commonly along branches of CN V.94,95 Infiltration can lead
to a distinct parasellar syndrome, with neuropathies frequently
involving CNs III and V.96 On MRI, osseous metastases
are typically identified as hypointense geographic areas of
marrow replacement on noncontrast T1-weighted sequences.
Because marrow fat is normally hyperintense on both T1-
and T2-weighted sequences, fat saturation is useful to visualize
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FIGURE 18. Epidermoid tumor. A, Sagittal noncontrast T1-weighted image shows an extra-axial lesion
(white arrows) in the suprasellar region and anterior to the brain stem. Its signal intensity is slightly higher
than that of CSF.B, Axial T2-weighted image shows mild heterogeneity within an otherwise cystic-appearing
lesion.C, Axial FLAIR demonstrates heterogeneous signal with a so-called “dirty” appearance (black arrows).
D, Axial diffusion-weighted image shows increased signal from the lesion (arrowheads).
metastases after administration of intravenous contrast material
(Figure 15). Diffusion-weighted imaging may improve detection
of calvarial metastases by showing areas of increased marrow
signal, with the exception of prostate cancer, which is primarily
sclerotic.97,98
In contradistinction, pituitary metastases are relatively rare.
They are most frequently secondary to lung and breast cancer
(more than one-half of cases), followed by renal and colorectal
cancer.99 Pituitary metastasis present as a mass involving the
pituitary stalk or gland, may have a waist at the diaphragma
sellae, can extend cranially to involve the hypothalamus, and the
majority show loss of the pituitary bright spot and avid contrast
enhancement.99 Their distinction from adenomas is difficult.
While smooth expansion of the sella favors an adenoma, erosion
of the sella or skull base does not necessarily indicate a metastasis,
as macroadenomas can be large and infiltrative.100 Edema along
the optic tracts may be present but is a nonspecific finding that
can be seen in a variety of tumors.101
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FIGURE 19. Ruptured dermoid tumor. Sagittal noncontrast T1 shows a
predominantly hyperintense suprasellar mass (arrow). Hyperintense lipid
material can be seen in the lateral and fourth ventricles, quadrigeminal and
prepontine cisterns, and posterior fossa.
CONGENITAL
Rathke Cleft Cyst
These are benign, true epithelial cysts believed to arise from
remnants of Rathke’s pouch due to incomplete obliteration of
the embryonic cleft.30 They are more common in females, with
symptomatic patients usually presenting between ages 30 and 60,
although they may be seen at any age.30,102 While the majority
of them are small, asymptomatic, and found incidentally (in up
to 33% of pituitary glands at autopsy), they may occasionally
grow and cause mass effect.102,103 Their contents are almost
always homogeneous, but their signal characteristics on MRI
vary according to the presence of protein, mucopolysaccharides,
and, rarely, hemorrhage.104 They are located centrally or near
centrally within the pituitary gland (typically without deviation
of the stalk) between the pars distalis and the pars intermedia
but may also have suprasellar extension (Figure 16).18,102 While
they are frequently hyperintense on T2-weighted images, lesions
that are homogeneously T2 hypointense are highly suggestive
of the diagnosis, as is the presence of a T1-hyperintense and
T2-hypointense intracystic nodule (representing a mucinous
mass with cholesterol and protein) (Figure 17).103,105,106 Aside
from intracystic nodules and epithelial rests, they do not have
solid components, do not enhance with contrast material, and
rarely calcify.104 Rathke cleft cysts may rarely be complicated by
infection, hemorrhage, or chemical meningitis.107,108
Dermoid and Epidermoid Tumor
Both of these nonneoplastic lesions develop from inclusion
of ectodermal remnants during neural tube closure and differ
histopathologically in that dermoids contain dermal appendages
and epidermoids do not.109,110 They both accumulate desqua-
mated debris from their capsules and grow slowly.109 Despite
being congenital, they are infrequently found in children and
usually manifest later in life.109 Both are rare, but dermoids are
less common.108 Their location may vary, but dermoids are more
commonly found midline while epidermoids tend to occur off-
midline or asymmetrically to one side.108,110 Between 40% and
50% of intracranial epidermoids occur in the cerebellopontine
angles, 30% are parasellar, and 25% are primarily intraosseous
with potential involvement of the subdural space.111
On CT, most epidermoids have low density that approaches
CSF and may be difficult to distinguish from arachnoid cysts.
Increased density in a minority of them may result from hemor-
rhage, increased protein, or saponification.112,113 On MRI,
their T1 and T2 signal intensities are usually close to those
of CSF, but the lesion does not suppress on fluid-attenuated
inversion recovery (FLAIR) sequences, on which it shows a
“dirty” appearance (Figure 18).114 Classically, they demonstrate
very high (“light bulb bright”) signal intensity on diffusion-
weighted sequences, with ADC values that may not be as low
as expected, probably from a combination of restricted diffusion
and T2 shine-through effects.114,115 Calcification is present in
10% of epidermoid tumors.116 Dermoids tend to follow fat
characteristics on CT and MRI but may be hypointense on T2
(Figure 19). Except for a thin peripheral rim in some, dermoids
and epidermoids do not enhance.116,117 Malignant transfor-
mation to squamous cell carcinoma is rare and can be seen in
both lesions but is more common in epidermoids.118
Arachnoid Cyst
Arachnoid cysts are benign nonneoplastic structures filled with
CSF and lined by arachnoid cells and collagen.119 They are more
common in males and have an imaging prevalence of 1% to 3%,
with 75% found in children.120,121 Between one-third and one-
half are located in the middle cranial fossa, followed by the retro-
cerebellar region.121,122 Growth is rare for incidentally found cysts
and the majority are asymptomatic, although they occasionally
may result in obstructive hydrocephalus, cranial neuropathies,
seizures, or headaches.121 Lack of or incomplete communication
between the cyst and subarachnoid space is thought to be a factor
in the development of mass effect and progressive symptoms.123
While this has traditionally been assessed with CT cisternog-
raphy, more recent studies have focused on the use of phase-
contrast MRI to document jet-like flow within communicating
arachnoid cysts or on the demonstration of cyst walls using
SSFP sequences (Figure 20).123-125 Arachnoid cysts are well-
demarcated, expansile, and unilocular lesions without internal
architecture, which often result in osseous remodeling.83,126 Most
arachnoid cysts follow CSF signal intensity on all MRI sequences
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FIGURE 20. Arachnoid cyst. A, Sagittal noncontrast T1-weighted image shows an extra-axial lesion with
CSF signal intensity (arrows). B, Axial FLAIR shows suppression of signal from the lesion (arrowheads). C,
Sagittal noncontrast CISS delineates the walls of the cyst and its mass effect on the diencephalic structures
and optic nerves. D, Axial postcontrast T1-weighted image shows no enhancement within the lesion.
and suppress on FLAIR, except for some that may contain
increased proteins or hemorrhage.126
Hypothalamic Hamartoma
These are benign lesions consisting of neuronal and glial
tissues that arise from the inferior hypothalamus or tuber
cinereum.127,128 They are classically associated with gelastic
seizures, precocious puberty, and developmental delay, although
there is considerable variability in their presentation.129 Hamar-
tomas can develop along the floor of the third ventricle or within
the hypothalamus proper or be pedunculated, often with attach-
ments to the mammillary bodies or tuber cinereum.129,130 On
MRI, they do not strictly follow gray matter signal intensity,
and most are mildly hyperintense on T2 (probably due to
glial tissue) and iso- to hypointense on T1-weighted sequences
(Figure 21).128-130 Like normal brain parenchyma, hamartomas
have a functional blood–brain barrier and should not show
contrast enhancement.130
VASCULAR
Giant Aneurysm
Most aneurysms are thought to develop from a combination of
hemodynamic stress and acquired or inherited factors (including
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FIGURE 21. Hypothalamic hamartoma. A, Sagittal noncontrast T1-weighted image shows a mass (white
arrow) along the floor of the third ventricle. The lesion is isointense to cortex. B, Coronal FLAIR shows that
the lesion (black arrow) is mildly hyperintense relative to cortex.
connective tissue disorders) that result in progressive weakening
of the parent vessel.131 Giant aneurysms are greater than 25 mm
in diameter and are rare but important lesions that may occur
in the suprasellar or parasellar regions.132 Their recognition is
critical due to treatment implications and, most importantly, to
avoid a catastrophic biopsy. Giant aneurysms can cause osseous
erosion of the skull base and may occasionally extend to the
parapharyngeal space, paranasal sinuses, or infratemporal fossa.133
Their imaging characteristics may be misleading, with heteroge-
neous signal intensities and incomplete enhancement owing to
thrombosis and blood at various stages. Areas of profound T2
hypointensity within a skull base mass may represent a vascular
flow void, and the lesion should be carefully scrutinized to rule out
an aneurysm. Pulsation artifact in the phase-encoding direction
may be a useful clue when present (Figure 22).
INFLAMMATORY/GRANULOMATOUS
Sarcoidosis
Autopsy studies have found subclinical CNS involvement in
25% of patients with systemic sarcoidosis.134,135 This can involve
any part of the brain, meninges, cranial nerves, or calvarium,
and its appearance is nonspecific, with leptomeningeal or pachy-
meningeal thickening and enhancement and/or cerebral or soft-
tissue granulomata.136 Infiltration of the pituitary gland and
infundibulum/hypothalamus is rare and generally proportional
to disease severity but can rarely occur in isolation (which may
mimic the appearance of lymphocytic hypophysitis or Langerhans
cell histiocytosis).135 More commonly, hypothalamic/pituitary
involvement is associated with nodular leptomeningeal basilar
enhancement.135-137 As with other granulomatous infections,
sarcoid lesions may be hypointense on T2-weighted images, but
this finding is nonspecific (Figure 23).137
Lymphocytic Hypophysitis
Lymphocytic hypophysitis is an infiltrative autoimmune/
inflammatory disorder that may affect the anterior or posterior
pituitary gland or infundibulum and is characterized by variable
degrees of pituitary dysfunction.138 It is most commonly seen
in pregnant or postpartum patients but has also been linked
to a number of autoimmune conditions, including drug related
(eg, ipilimumab).139 Its imaging appearance is nonspecific and
may be indistinguishable from other infiltrative processes such
as Langerhans cell histiocytosis and may also be confused with
primary or metastatic neoplasms. It usually leads to thick-
ening and avid enhancement of the affected portions of the
gland, sometimes with absence of the pituitary bright spot
(Figure 24).140 In some patients, a T2-hypointense area is seen
in the parasellar region, which may suggest the diagnosis.138
CONCLUSION
The sellar and parasellar regions are relatively small areas
of the skull base that harbor important neurovascular struc-
tures and feature complex anatomy. The pathology that can
occur at these sites is varied, and some of the diseases
may present with similar clinical and imaging characteristics.
Knowledge of relevant neuroimaging features may assist in
characterization of these lesions, delineation of their extent, and
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FIGURE 22. Giant parasellar aneurysm. A, Coronal noncontrast T1-weighted image shows a partially
thrombosed aneurysm (black arrowheads) along the right aspect of the sella and middle cranial fossa. B,
Coronal postcontrast T1-weighted image shows enhancement of the nonthrombosed inferior portion of the
aneurysm (black arrow). C, Axial T2-weighted image demonstrates a vascular flow void (white arrowhead)
related to the perfused portion of the aneurysm. D, Axial FLAIR image shows the presence of pulsation
artifact along the phase-encoding direction (white arrows).
FIGURE 23. Neurosarcoid. A, Sagittal postcontrast T1-weighted image shows enhancing tissue in the hypothalamus
and along the upper pituitary infundibulum (white arrow) as well as leptomeningeal enhancement along the falx
cerebri. B, Coronal postcontrast T1-weighted image shows that the lesion partially encases the prechiasmatic optic
nerves. There is leptomeningeal enhancement along the falx cerebri and there are granulomas in the corpus callosum.
C, Axial T2-weighted image shows the suprasellar sarcoid granuloma to be hypointense (black arrow).
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FIGURE 24. Autoimmune hypophysitis in a patient with hypopituitarism following ipilimumab infusion for
melanoma. A, Baseline noncontrast sagittal T1-weighted image shows a normal configuration of the pituitary gland.
B, Sagittal postcontrast T1-weighted image 9 days after ipilimumab infusion shows enlargement and enhancement
of the pituitary gland (arrow) and infundibulum. C, Sagittal postcontrast T1-weighted image 5 days later shows
decreased size and enhancement of these structures.
awareness of potential mimics prior to diagnostic biopsy or
resection.
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